Real science is never settled, and anyone who has certainty on such things is not qualified to discuss it.
If twice didn’t work (Moderna and Pfizer vaccines), 3rd time booster the fix?
The Epoch Times: More Than Half of Israeli COVID-19 Patients Vaccinated as ‘Breakthrough Cases’ Rise
By Lorenz Duchamos, August 20, 2021
In Israel’s COVID-19 wards, nearly 60 percent of the country’s 514 patients hospitalized with severe or critical CCP (Chinese Communist Party) virus symptoms are fully vaccinated, according to an Aug. 16 report.
...There are so many breakthrough infections that they dominate, and most of the hospitalized patients are actually vaccinated,” said Uri Shalit, a bioinformatician at the Israel Institute of Technology, Science reported.
For the majority of patients experiencing breakthrough infections, about 87 percent were 60 or older and received two vaccine doses at least five months ago. The findings show that “breakthrough cases” are not a rare event as the term implies.
...Israel is among the world’s highest vaccination levels, with some 5.4 million people—or 78 percent of those 12 and older—fully vaccinated... Noa Eliakim-Raz, the chief of the COVID-19 ward at Rabin Medical Centre in Petach Tikva, said the majority of hospitalized vaccinated patients are unhealthy, immobile and already required nursing care prior to infection.
WIND: even adjusting for the vaccinated vs unvaccinated proportions of the population, the numbers are startlingly high where it really counts: vaccinated people being hospitalized. So high that it makes me want to see a lot better analysis over here in the USA.
Who is most likely to contract COVID and have serious symptoms? The elderly of course, vaccinated or not. You would expect that the elderly would both be (a) vaccinated, (b) less likely to mount a strong immune response to the vaccine, and therefore likely to present with serious problems. So I would call this article misleading at best, at least as stated, because it lacks objective analysis.
Still, when the vaccine trials specifically excluded the cohort most in need of the vaccine (the infirm elderly), we were flying blind. Now the fog is clearing and there might be reason for concern.
Is it just that the vaccine has poor efficacy in the elderly, or could there be antibody dependent enhancement at work in some cases?
In life, repeating what didn’t work and hoping for different results is a sign of stupidity. But to be fair, the Trump COVID vaccines are more like partially effective prophylactics than real vaccines (with waning efficacy), but they do appear to “work” in reducing severe disease and death. So that even with reduced efficacy for the elderly (as is always the case for vaccines in weaker bodies), vaccines still have a lot of value if they reduce serious disease and mortality in the elderly.
It sure would be nice to get detailed analysis out of the authorities (updated weekly) and based on real science (both PCR and antibody tests), but it is totally lacking. As is the assignment of causal factors, which is illegitimately assigned to COVID (with COVID vs from COVID). So we keep working with GIGO data analysis.